These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 27497504)

  • 21. Advances in the management of statin myopathy.
    Gallo A; Perregaux J; Bruckert E
    Curr Opin Endocrinol Diabetes Obes; 2021 Apr; 28(2):142-151. PubMed ID: 33278129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AMG 145, a monoclonal antibody against PCSK9, facilitates achievement of national cholesterol education program-adult treatment panel III low-density lipoprotein cholesterol goals among high-risk patients: an analysis from the LAPLACE-TIMI 57 trial (LDL-C assessment with PCSK9 monoclonal antibody inhibition combined with statin thErapy-thrombolysis in myocardial infarction 57).
    Desai NR; Giugliano RP; Zhou J; Kohli P; Somaratne R; Hoffman E; Liu T; Scott R; Wasserman SM; Sabatine MS
    J Am Coll Cardiol; 2014 Feb; 63(5):430-3. PubMed ID: 24161333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intermittent nondaily dosing strategies in patients with previous statin-induced myopathy.
    Keating AJ; Campbell KB; Guyton JR
    Ann Pharmacother; 2013 Mar; 47(3):398-404. PubMed ID: 23482733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statin-Associated Muscle Adverse Events: Update for clinicians.
    Al-Mohaissen MA; Ignaszewski MJ; Frohlich J; Ignaszewski AP
    Sultan Qaboos Univ Med J; 2016 Nov; 16(4):e406-e415. PubMed ID: 28003885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
    J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PCSK9 inhibitors--past, present and future.
    Reiner Ž
    Expert Opin Drug Metab Toxicol; 2015; 11(10):1517-21. PubMed ID: 26329686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Approach to Patients with Statin Intolerance: Evidence-Based Review].
    Almeida JT; Esteves AL; Martins F; Palma I
    Acta Med Port; 2020 Jan; 33(1):49-57. PubMed ID: 31928603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of ezetimibe in patients who cannot tolerate statins or cannot get to the low density lipoprotein cholesterol target despite taking a statin.
    Gazi IF; Daskalopoulou SS; Nair DR; Mikhailidis DP
    Curr Med Res Opin; 2007 Sep; 23(9):2183-92. PubMed ID: 17692154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [ANMCO Position paper: Diagnostic and therapeutic pathways in patients with hypercholesterolemia and statin intolerance].
    Gulizia MM; Colivicchi F; Arca M; Abrignani MG; Perna GP; Mureddu GF; Nardi F; Riccio C;
    G Ital Cardiol (Rome); 2016 Jun; 17(6):447-55. PubMed ID: 27311087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statin myopathy: over-rated and under-treated?
    Maghsoodi N; Wierzbicki AS
    Curr Opin Cardiol; 2016 Jul; 31(4):417-25. PubMed ID: 27258372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of Statin Intolerance in 2018: Still More Questions Than Answers.
    Toth PP; Patti AM; Giglio RV; Nikolic D; Castellino G; Rizzo M; Banach M
    Am J Cardiovasc Drugs; 2018 Jun; 18(3):157-173. PubMed ID: 29318532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Ezetimibe Alone or in Addition to a Statin on Plasma PCSK9 Concentrations in Patients with Type 2 Diabetes and Hypercholesterolemia: A Pilot Study.
    Miyoshi T; Nakamura K; Doi M; Ito H
    Am J Cardiovasc Drugs; 2015 Jun; 15(3):213-9. PubMed ID: 25896669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical use of ezetimibe.
    Cheng AY; Leiter LA
    Can J Clin Pharmacol; 2003; 10 Suppl A():21A-5A. PubMed ID: 14571302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin D deficiency, myositis-myalgia, and reversible statin intolerance.
    Glueck CJ; Budhani SB; Masineni SS; Abuchaibe C; Khan N; Wang P; Goldenberg N
    Curr Med Res Opin; 2011 Sep; 27(9):1683-90. PubMed ID: 21728907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of statin-intolerant patient.
    Arca M; Pigna G; Favoccia C
    Panminerva Med; 2012 Jun; 54(2):105-18. PubMed ID: 22525565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statin tolerability: In defence of placebo-controlled trials.
    Tobert JA; Newman CB
    Eur J Prev Cardiol; 2016 May; 23(8):891-6. PubMed ID: 26318980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alirocumab: A Review in Hypercholesterolemia.
    Greig SL; Deeks ED
    Am J Cardiovasc Drugs; 2016 Apr; 16(2):141-52. PubMed ID: 26935836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative evaluation of statin effectiveness versus intolerance and strategies for management of intolerance.
    Soran H; France M; Adam S; Iqbal Z; Ho JH; Durrington PN
    Atherosclerosis; 2020 Aug; 306():33-40. PubMed ID: 32683135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination regimens with statin, niacin, and intestinally active LDL-lowering drugs: alternatives to high-dose statin therapy?
    Guyton JR
    Curr Opin Lipidol; 2010 Aug; 21(4):372-7. PubMed ID: 20625257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expert opinion: the therapeutic challenges faced by statin intolerance.
    Patel J; Martin SS; Banach M
    Expert Opin Pharmacother; 2016 Aug; 17(11):1497-507. PubMed ID: 27254275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.